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Porous biomaterials using polymers, ceramics, metals, or glasses, have been extensively 
studied, and are widely used as scaffolds for tissue and bone regeneration in a multi-
millionaire market context.[1,2] Porous scaffolds provide a three-dimensional environment that 
preserves tissue volume, supports cell interactions and, in some cases, delivers biological 
agents for repairing, maintaining, restoring or improving the function of organs and tissues.[3] 
In all these cases, it is highly desirable to have scaffolds that can regulate the delivery of 
biological agents (for instance, drugs, cells, etc.) because control over release can improve the 
safety and efficiency of agents, and allows the design of advanced scaffolds and new therapies. 
However, most of the porous scaffolds currently used in tissue engineering are mainly non-
active; that is, they deliver biological agents through passive mechanisms which typically 
involve material degradation coupled with molecular diffusion.[4-11] Moreover, the drug 
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release kinetics of these systems is usually uncontrolled and supports are unable to retain the 
drug payload for a long time.[12]  
From a different point of view, progress in bio-molecular chemistry and nanotechnology have 
recently resulted in the design of biologically inspired systems with innovative bio-related 
functions and fuelling areas, such as bio-engineering, bio-sensing, bio-nanotechnology and 
drug delivery in new directions. Drug-delivery systems capable of releasing active molecules 
in a controlled manner have recently gained much attention. In this field, mesoporous silica 
nanoparticles (MSN) have been widely used as reservoirs for drug storage given their unique 
mesoporous structure, large specific volume and easy functionalisation.[13] Additionally, MSN 
can be functionalised with molecular/supramolecular ensembles on their external surface to 
develop gated MSN which show “zero delivery” (i.e., the hybrid material is unable to release 
the payload), but are capable of releasing their cargo in response to external stimuli.[14-18] The 
great potential of designing a hybrid material with nanometric controlled delivery features has 
motivated scientists to develop a wide variety of stimuli-responsive MSN-capped systems 
capable of being opened by chemical[19-25] (i.e., redox molecules, selected anions, pH changes 
and biomolecules), physical[26-31] (i.e., light, temperature or magnetic fields) or biochemical[32-
37] triggers. 
Given the need to develop scaffolds for advanced therapies which can improve features of 
conventional systems, in this communication, we show for the first time (as far as we are 
aware) a new approach to design tailor-made scaffolds capable of displaying selective and 
controlled cargo delivery based on the combination of suitable 3D supports and gated 
mesoporous materials. As a proof of concept, our strategy involves the preparation of a 
biomaterial of potential application in bone tissue engineering. It consists of a macroporous 
scaffold, prepared by rapid prototyping (RP) techniques, that incorporates capped MSN 
designed to deliver the cargo under specific events. In particular, the designed MSN can be 
opened on command in the presence of acid phosphatase (APase), an enzyme whose 
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concentration is used to assess osteoclast activity in bone remodelling processes[38-39] and as a 
biochemical marker for the presence of bone metastases.[40,41] Accordingly, this stimuli-
responsive “gated scaffold” opens up new alternatives to treat osteoporotic fractures and bone 
cancer.  
 
 
 
 
 
 
 
 
 
Scheme 1. Schematic representation of the APase-driven MSN system.  
 
For this study, MCM-41-based MSN (ca. 100 nm) were selected as the inorganic scaffold. 
Calcined MSNs were loaded with tris(2,2’-bipyridyl)ruthenium(II) chloride and the external 
surface of the silica mesoporous nanospheres was functionalised with 3-[2-(2-
aminoethylamino)ethylamino]propyl-trimethoxy silane to yield solid S1. The final material 
(solid S2) was obtained by treating the neutral aqueous solutions of S1 with adenosine 
triphosphate (ATP). This is expected to cap the pores by the formation of a dense network in 
pore outlets through supramolecular hydrogen-bonding interactions, and electrostatic forces 
between the large negatively charged ATP anions and the positively charged ammonium 
groups on MSN. The presence of ATP in S2 would inhibit cargo release, whereas the 
hydrolysis of the ATP cap by APase is anticipated to induce it, as depicted in Scheme 1. 
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The calcined starting MSN and solids S1 and S2 were characterised by standard techniques. 
Figure 1A shows the diffraction pattern of the prepared solids, which display typical features 
of the MCM-41 phase, indicating that the mesopores in the nanoparticles were preserved 
throughout the filling process, external amines anchoring and capping with ATP. Figure 1B 
depicts a representative TEM image of solid S2, in which the black and white strips, typical of 
the porosity of the MCM-41 phase, can be clearly seen.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. (A) Powder X-Ray diffraction pattern of a) starting calcined MCM-41, b) 
nanoparticulated S2, c) S3 scaffold (vide infra). (B) Representative TEM image of the S2 
gated nanoparticles. (C) Kinetic dye release studies done at 37ºC in water of ATP-capped 
solid S2 a) in the presence and b) absence of APase.  
 
The N2 adsorption-desorption isotherm of the starting calcined MSN showed a typical type-IV 
curve from which a specific surface area of 931.5 m2g–1, a narrow pore size distribution and 
an average pore diameter of 2.39 nm were calculated. In contrast, the N2 adsorption-
desorption isotherm of final gated materials S2 was typical of the capped and filled 
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mesoporous systems. In this case, a lower N2 adsorbed volume and a smaller surface area 
(24.6 m2g–1) were found when compared with the starting material (see Supporting 
Information for further details). Moreover, the organic content of solids S1 and S2 calculated 
from thermogravimetry and elemental analysis are shown in Table 1.  
Table 1. Organic content (α, mmol/g of solid) in solids S1 and S2  
 αdye αpolyamine  αATP 
S1 0.16 1.70 -- 
S2 0.04 1.35 0.14 
 
After characterisation, cargo release studies were carried out with S2. In a typical experiment, 
4 mg of S2 were suspended in water in both the presence and absence of APase. Suspensions 
were kept at 37ºC, and at certain time intervals, fractions of both suspensions were taken and 
centrifuged to remove the solid. Dye delivery into the solution was then measured by the 
fluorescence of [Ru(bpy)3]
2+ at 593 nm (λex 454 nm). The delivery profiles of [Ru(bpy)3]2+ in 
both the presence and absence of APase enzyme are shown in Figure 1C. As seen, 
nanoparticles S2 are tightly capped in the absence of APase and show a negligible release of 
[Ru(bpy)3]
2+ (Figure 1C, curve b); in contrast, the presence of APase induces the opening of 
the pores and the subsequent cargo release.  
 
The observed performance confirms the proposed paradigm. When APase enzyme is absent, 
ATP molecules interact strongly with the polyamines anchored in S2 and are able to block the 
release of the entrapped dye. However in the presence of APase, the enzyme hydrolyses the 
phosphate-phosphate ATP bonds by disassembling the polyamine-phosphate interactions, and 
by inducing the pore aperture and the subsequent dye release. The APase-mediated hydrolysis 
of ATP in S2 was confirmed by STEM-EDX studies which, in turn, confirmed that the P/Si 
ratio in S2 was 3-fold lower when the solid was treated with APase. Moreover 31P-NMR 
studies done in the aliquots collected in the release studies clearly showed the presence of 
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increasing amounts of phosphate (at  +2.1 ppm), which correlated well with the amount of 
released cargo. Finally, in order to further confirm that the uncapping mechanism was driven 
by APase, dye release studies on S2 in the presence of other enzymes, such as esterase and 
pepsin, and in the presence of denatured APase, were performed. Under these conditions, no 
significant cargo release was observed (see Supporting Information).  
Bearing in mind the promising results obtained with capped solid S2, we take a step forward 
towards the possibility of designing gated 3D macroporous scaffolds for potential applications 
for filling bone defects. In these designed supports, the scaffold macropore system must be 
highly interconnected and large enough to support bone ingrowth and angiogenesis. 
Depending on the kind of the host bone, i.e. cortical or cancellous bone, these parameters can 
vary, but the pore size must be large enough to allow the formation of mature bone within the 
macropore arrangement, being considered an appropriate pore size a range between 300-2000 
micrometers for the bone ingrowth after implantation.[45,46] In this context many processes 
have been developed to prepare macroporous supports, such as replicas of porous sponges and 
coral exoskeletons, production of gas bubbles via gas evaporation, chemical reactions, and 
introduction of porogens (such as organic volatile particles) in a ceramic slip and gel-casting, 
either alone or in combination with a multiple tape-casting method.[42-44] However, pore size, 
shape and its interconnectivity, cannot be fully controlled in these approaches. In contrast, 
rapid prototyping (RP) is a good alternative to fulfil requirements for manufacturing suitable 
scaffolds for different clinical applications and individuals. Following these concepts, the S2 
nanoparticles were incorporated into a 3D gelatin framework produced using rapid 
prototyping 3D printing[40,41] to obtain the final gated 3D scaffold S3. 
In a typical experiment to prepare S3, an aqueous solution of gelatin at 37ºC was mixed with 
S2 nanoparticles under vigorous stirring. Then a solution containing glutaraldehyde as a 
cross-linker was added. The mixture was stirred at room temperature until it formed a paste of 
appropriate consistency for injection. The scaffold was fabricated by direct ink deposition 
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over a pre-cooled plate to build 3D-pieces with tetragonal symmetry. After frizzing samples, 
they were cut into smaller ca. 6×6×4 mm new dimensions, and were once again placed in a 
glutaraldehyde solution. Finally after a new freeze and drying process, S3 was obtained.  
The S3 gated scaffolds were characterised by X-ray diffraction (XRD), thermogravimetry and 
SEM. The presence of the (100) reflection in the S3 XRD pattern (Figure 1Ac) confirmed 
mesostructure preservation during the scaffold manufacturing process. From the 
thermogravimetric analysis, a content of 25±3% in weight of SiO2 was calculated. It is 
estimated that around 35% in weight of S3 is composed of S2 nanoparticles. The SEM 
analysis of the S3 scaffolds showed several porosity levels, resulting in a hierarchical porous 
system. At the macroscopic level, S3 presented orderly distributed pores from 900 to 1200 µm, 
which are the product of the porosity architecture designed by the rapid prototyping of the 
scaffold surface and the scaffold fracture, respectively (Figure 2A and B). A second porosity 
level is also observed (Figure 2C and D) in the sinus of the scaffold walls. This second level 
is formed by pores from 40-100 µm, whose size and presence are determined by the degree of 
cross-linking of the gelatin. This macroporosity makes the permeability of the surrounding 
medium possible (in which the APase can be included) in the inner scaffold walls. Finally, the 
images taken at higher magnifications (Figure 2D and E) show a sponge-like structure 
formed by gelatin covers that surrounds the S2 nanoparticles. The observed scaffold features 
were also studied by EDX analysis, which was performed at several S3 sites (Figure 2F). The 
presence of Si and P in the magnified images of S3 confirmed the incorporation of the S2 
nanoparticles into the scaffold. Moreover, in vitro degradability of S3 in water was studied. In 
a typical experiment, a piece of 8 mg of S3 was placed in 1 mL of distilled water under orbital 
stirring at 37 ºC. The weight of the hydrated scaffolds was measured after ten months and 
only a 10 % of weight lost was observed.  
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Figure 2. (A) SEM Image at low magnifications of the S3 surface and (B) the S3 fracture, 
showing giant macroporosity. (C) Image of S3 at high magnifications in which a second 
porosity level can be observed due to the gelatin cross-linking, (D) second macroporosity 
level showing the incorporated S2 nanoparticles. (E) Higher magnification shows a wall 
scaffold with embedded S2 nanoparticles. (F) EDX microanalysis of image E at sites 1 (wall) 
and 2 (S2 nanoparticles). (G) Dye release kinetics in PBS at 37ºC from S3 (a) in the presence 
and (b) absence of APase. SEM micrographs of the scaffolds after 48 hours of HOS culture. 
(H) Detail of c.a. 900 µm macropore prepared by 3D printing.  The selected area indicates a 
fully coated border site by HOS cells; higher magnification of this area (I). (J) Transversal 
section of the scaffolds; double arrow points the channel width and dotted lines mark the 
struts. The selected area is magnified in (K), where spread HOS cells can be observed 
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(arrows).(L) Cell proliferation assay after 3 and 5 days of culture. Significant differences were 
observed between the control and scaffolds results for cell proliferation tests. *(p<0.05). 
 
Then release studies were performed. In a typical experiment, “gated scaffold” S3 was 
immersed in a PBS solution in the presence and absence of APase. Both solutions were stirred 
for 50 h at 37ºC and, at a set time, an aliquot of each experiment was taken to monitor cargo 
release. The obtained results are shown in Figure 2G. As observed, delivery was found only 
when the enzyme was present, thus confirming that the APase-driven release mechanism 
found for S2 was maintained in the S3 scaffold. Slower release kinetics was also found for S3 
when compared with S2, most probably due to the enzyme’s different accessibility to the 
hierarchical hybrid structure in the gated scaffold when compared with free nanoparticles. The 
permeability of these 3D scaffolds to large macromolecules was confirmed after placing them 
in a solution with fluorescein-labelled avidin macromolecules as an enzyme model. After 1 
day, scaffolds were sliced into thin films and intense fluorescence was observed in all the 
pieces (see Supporting Information). As far as we know, this is the first example of gated 
scaffolds obtained by combining biomaterials and gated stimuli-controlled nanoparticles.  
Finally, in order to assess the biocompatibility of the scaffold, in vitro cell culture tests were 
carried out on 3D gelatin framework containing silica nanoparticles. For that pourpose, a 
human osteoblast-like cell line denoted HOS was used. Cell proliferation, cytotoxicity and 
spreading assays were performed (see Supporting Information for further details). In these 
experiments (see Figure 2L) it was found that HOS cells proliferate even better than in the 
control (plastic culture plate), and the LDH levels do not show significant differences in the 
presence of the scaffolds compared with the control ones, indicating that the scaffolds do not 
elicit any cytotoxic effect. Finally, SEM micrographs (see Figures 2H-K) confirmed that 
HOS cells adhere, proliferate and spread well within the scaffold, confirming that the 
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macroporous architecture and the strut thickness is appropriated for the scaffold colonization 
by HOS cells.  
 
In summary, we report herein a new approach for the design of “gated scaffolds” which 
consists in combining capped silica mesoporous nanoparticles and classical porous 
biomaterials. In particular, we have prepared MSN functionalised with amines and capped 
with ATP, which can be selectively opened with an APase enzyme. We have also integrated 
capped nanoparticles into a 3D gelatin support prepared by rapid prototyping 3D printing 
techniques. The obtained “gated scaffold” remains tightly capped in competitive aqueous 
buffered solutions yet is able to deliver the cargo in the presence of APase. The present study 
has focused on the capability of active gelatin-based 3D macroporous scaffolds for on-
command cargo delivery in the presence of APase, an enzyme whose concentration is used to 
assess osteoclast activity in bone remodelling processes and as a marker for bone metastases. 
We also expect this general gated scaffolds preparation approach, will find broader 
applications. In particular, the combination of gated nanoparticles, which can be opened at 
will using chemical, physical or biochemical stimuli with different supports based on 
polymers, ceramics or metals, opens up the possibility of preparing a number of advanced 
gated scaffolds, which we envision can help find applications in regenerative medicine and 
bone cancer therapy.  
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A new approach towards the design of “gated scaffolds” based on the combination of 
capped mesoporous silica nanoparticles (MSN) with porous biomaterials is reported. 
Using this approach, a 3D gelatin-based scaffold able to selectively deliver cargo in the 
presence of an APase enzyme is prepared and tested. This new design opens up the possibility 
of developing new smart biomaterials with advanced drug delivery features. 
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Chemicals 
The chemicals tetraethylorthosilicate (TEOS) (98 %), n-cetyltrimethylammonium bromide 
(CTAB) (≥99 %), sodium hydroxide (≥98 %), tris(2,2’-bipyridyl)ruthenium(II) chloride 
hexahydrate, 3-[2-(2-aminoethylamino)ethylamino]propyl-trimethoxysilane, adenosine 5’-
triphosphate disodium salt hydrate (ATP), acid phosphatase from potato (APase), gelatin Ph 
Eur and glutaraldehyde 50 wt.% solution in water where purchased from Aldrich. 
Na2HPO4•7H2O, KH2PO4 , NaCl and KCl where purchased from Scharlab. All reagents were 
used as received. 
 
General Techniques 
Powder XRD, TG analysis, ele-mental analysis, TEM, SEM, zeta potential measurements, 
and N2 adsorption-desorption techniques were employed to characterize the prepared 
materials. Powder X-ray diffraction measurements were performed on a Philips D8 Advance 
diffractometer using Cu Kα radiation. Thermogravimetric analysis were carried out on a 
TGA/SDTA 851e Mettler Toledo balance, using an oxidant atmosphere (air, 80 mL/min) with 
a heating program consisting on a heating ramp of 10⁰C per minute from 393 to 1273 K and 
an isothermal heating step at this temperature during 30 minutes. Elemental analysis was 
performed in a CE Instrument EA-1110 CHN Elemental Analyzer. TEM images were 
obtained with a 100 kV Jeol JEM-1010 microscope. Z potential measurements were 
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performed in a Zetasizer Nano instrument from Malvern. N2 adsorption-desorption isotherms 
were recorded on a Micromeritics ASAP2010 automated sorption analyser. The samples were 
degassed at 120⁰C in vacuum overnight. The specific surface areas were calculated from the 
adsorption data in the low pressures range using the BET model. Pore size was determined 
following the BJH method. STEM analysis was performed with a 200kV Jeol JEM 2100F. 31P 
nuclear magnetic resonance (NMR) was acquired with a Brucker Avance III. Surface and 
cross-sectional scanning electron microscopy (SEM) micrographs of S3 and EDX analysis of 
the scaffolds were recorded with a field emission scanning electron microscope (JEOL model 
JSM-6335, Tokyo, Ja-pan) at an acceleration voltage of 15 kV. For scaffolds manufacture, an 
EnvisionTEC GmbH 3-D Bioplotter™ was used. In release experiments, fluorescence 
spectroscopy was carried out with a Jasco Spectrofluorometer FP-8500.  
 
Synthesis of the mesoporous silica support 
The MCM-41 mesoporous nanoparticles were synthesised by the following procedure: n-
cetyltrimethylammonium bromide (CTAB, 1.00 g, 2.74 mmol) was first dissolved in 480 mL 
of deionised water. Then 3.5 mL of NaOH 2.00 M in deionised water were added to the 
CTAB solution. Next, the solution temperature was adjusted to 80°C. TEOS (5.00 mL, 2.57 × 
10-2 mol) was then added dropwise to the surfactant solution. The mixture was stirred for 2 h 
to give a white precipitate. Finally, the solid product was centrifuged, washed with deionised 
water and ethanol, and was dried at 60°C (MCM-41 as-synthesised). To prepare the final 
porous material (MCM-41), the as-synthesised solid was calcined at 550°C using an oxidant 
atmosphere for 5 h in order to remove the template phase, obtaining the porous material. 
 
Synthesis of S1.  
In a typical synthesis, 2.5 g of template-free MCM-41 were suspended in a solution of 1.5 g 
(2 mmol) of tris(2,2’-bipyridyl)ruthenium(II) chloride hexahydrate ([Ru(bpy)3]2+) dye in 80 
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mL of anhydrous acetonitrile in a round-bottomed flask. Then 10 ml of acetonitrile were 
distilled with a dean-stark, in order to remove the possible water present in the pores of the 
solid. Afterwards the mixture was stirred at room temperature during 24 hours. Subsequently, 
10 mL (15 mmol/g of MCM-41) of 3-[2-(2-aminoethylamino)ethylamino]propyl-
trimethoxysilane were added and the mixture was stirred for 5.5 h. Then the solid was filtered, 
washed with 10 mL of acetonitrile and dried at 37°C overnight to obtain the functionalised 
and filled solid S1.  
 
Synthesis of S2 
2.5 g of the loaded and prefunctional-ised solid S1 were suspended in a solution 0.01 M of 
ATP at pH 6 adjusted with H2SO4. This suspension was stirred for 5.5 hours at room 
temperature and then filtered under vacuum and washed with water at pH 6. This final solid 
S2 was dried under vacuum and stored at 37°C for 12 h.  
 
Synthesis of S3 
Gated MSN-scaffolds were prepared using S2 nanoparticles. In particular, 0.5 g of gelatin 
were dissolved in 3.75 mL of milli-Q water at 37°C. Thereafter, 0.3 g of S2 were slowly 
added under vigorous stirring. Once all the NPs were added, the mixture was stirred for 40 
min at 37°C. Finally, 2.50 mL of a glutaraldehyde as cross-linking solution 0.4% v/v was 
added. This mixture was stirred at room temperature until it formed a paste with appropriated 
consistency for injection. The paste was placed in polyethylene cartridge fixed with a 
dispensing tip of 0.51 mm (EFD-Nordson) internal diameter and the spacing between struts 
was set to 1.8 mm. The scaffolds were fabricated by direct ink deposition over a pre-cooled 
plate (10-15°C) by robocasting using an EnvisionTEC GmbH 3-D Bioplotter™. Each layer 
was 90° rotate to the next one, building 3D-pieces with tetragonal symmetry. The dimension 
of scaffolds was ca. 18 × 18 × 4 mm and consisted of 15 layers. They were frozen at -80°C for 
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2 h and they were cut on smaller ca. 6 × 6 × 4 mm new dimensions. The small scaffolds 
produced were then cross-linked by exposure to 10 mL of a 2.5% v/v glutaral-dehyde aqueous 
solution for 10 s. Finally, the scaffolds were freeze-dried at -80°C for 4 h. The final series ob-
tained were called S3.  
Calcined MCM-41, S1 and S2 characterization. 
All the mesoporous nanoparticles were characterized following standard techniques. The 
powder X-ray diffraction (XRD) pattern of the different synthesized solids is shown in Figure 
SI-1. In relation to the siliceous MCM-41 nanoparticles as synthesized the four low-angle 
reflections typical of a hexagonal array, indexed as (100), (110), (200), and (210) Bragg peaks 
are shown (curve a). A significant displacement of 4Å of the (100) peak in the XRD pattern of 
the MCM-41 calcined nanoparticles is evident in the X-ray pattern of MCM-41 calcined, due to 
further condensation of silanol groups during the calcination step (curve b). Finally, the X-ray 
diffraction pattern of both functionalized solids S1 and S2 can be observed in curves c) and d), 
respectively. An intensity decrease and a broadening of the (110) and (200) reflections can be 
appreciated, related to a loss of contrast due to the filling of the pore voids with the 
[Ru(bpy)3]Cl2∙6H2O dye and the external surface functionalization. Even so, the intensity of the 
(100) peak in this pattern strongly indicates that the mesoporous structure of the MCM-41 
scaffold has not been modified after the loading and functionalization processes in the final S2 
material. 
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Figure SI-1. (A) Powder X-Ray pattern of (a) MCM-41 as made, (b) MCM-41 calcined and (c) 
S1 solid and (d) S2 solid. 
Moreover, the presence of the mesoporous structure was confirmed by TEM analysis of the 
prepared solids. As it can be observed in Figure SI-2, the typical channels of the MCM-41 
matrix can be visualised as alternate black and white stripes in which the typical hexagonal 
porosity of the MCM-41 calcined material can also be observed. TEM images also show that 
the prepared MCM-41-based support is obtained as spherical nanoparticles with diameters 
ranging from 80 to 100 nm. TEM image of the final solid S2 (Figure SI-2b) also confirmed the 
ordered mesostructure of the final material. In that image, although the contrast between the 
black and white strips has decreased due to the loading of the pores with the dye, it can be 
confirmed that the spherical shape of the nanoparticles and their typical mesoporous structure 
remains.  
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Figure SI-2.  Representative TEM image of A) the inorganic MCM-41 calcined matrix. B) S2 
gated solid. 
N2 adsorption-desorption isotherms for calcined MCM-41 nanoparticles and the gated solid S2 
were registered and are shown in Figure SI-3. Curve a) corresponds to the calcined matrix 
showing a sharp adsorption step with a P/P0 value between 0.2 and 0.35, corresponding to a 
type IV isotherm, typical of these mesoporous materials. This first step is due to nitrogen 
condensation in the mesopore inlets. With the BJH model on the adsorption curve of the 
isotherm, the pore diameter and pore volume were calculated to be 2.39 nm and 0.69 cm3g-1, 
respectively. The absence of a hysteresis loop in this pressure range and the low BJH pore 
distribution (see inset in Figure SI-3) is due to the cylindrical uniformity of mesopores. The 
total specific area was 931.5 m2g-1, calculated with the BET model. Also using the a0 cell 
parameter 4.06 nm calculated form XRD measurements and the pore diameter (2.39 nm), a 
wall thickness value of 1.67 nm, was calculated. Other important feature of the curve is the 
characteristic H1 hysteresis loop that appears in the isotherm at a high relative pressure (P/P0> 
0.8) which can be closely associated with a wide pore size distribution which corresponds to 
the filling of the large pores among the nanoparticles (0.69 cm3g-1 calculated by the BJH 
model) due to textural porosity. In the case of the final S2 material, the N2 adsorption-
desorption isotherm is typical of mesoporous systems with filled mesopores (see Figure SI-3, 
curve b). In this way, and as it was expected, a lower N2 adsorbed volume (BJH mesopore 
100nm
B
100nm
A
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volume = 0.11 cm3g-1) and surface area (24.6 m2g-1) were determined, when compared with the 
initial MCM-41 material. As it can be observed in curve b, this solid presents a function with 
no gaps at low relative pressure values if compared to the mother MCM-41 array (curve a). A 
remarkable data is that S2 did not show a maximum in the pore size distribution curve, which 
can be explained by the presence of closed pores because of the entrapped dye and the 
functionalization moieties in the external surface. Table SI-1 shows a summary of the BET-
specific surface values, pore volumes and pore sizes calculated from the N2 adsorption-
desorption isotherms for MCM-41calcined and S2.  
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Figure SI-3. Nitrogen adsorption-desorption isotherms for (a) calcined MCM-41 mesoporous 
material (b) S2. Inset: Pore size distribution of calcined MCM-41 mesoporous material. 
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Table SI-1. BET specific surface values, pore volumes and pore sizes calculated from the N2 
adsorption-desorption isotherms for selected materials. 
 SBET (m
2g-1) 
Pore Volume 
(cm3g-1) 
Pore Size (nm) 
Calcined MCM-41 931.5 0.69 2.39 
S2 24.6 0.11 - 
 
Thermogravimetric studies of the final S2 solid were also carried out. The thermogravimetric 
curve showed four weight losses steps which could be associated to the following processes: 
7.00 % (T < 150 ⁰C, corresponding to solvent removal), 14.9 % (150 < T < 400 ⁰C, assigned to 
the decomposition of the organic moieties functionalizing the silica support), 12.8 % (400 < T 
< 550⁰C, also due to combustion of organics) and 0.364 % (T > 550 ⁰C, attributed to 
condensation of silanols in the siliceous surface).  
 
The surface charge of the synthesized nanoparticles was characterized using a Malvern 
Zetasizer Nano ZS instrumentation. After appropriate dilution of the different suspensions of 
the nanoparticles, the parameters of electrophoretic mobility (EM), zeta potential (ζ) and 
conductivity (σ) were determined. Samples from the prepared suspensions were diluted in ultra-
purified water and placed in the measurement cell. At least three different measurements were 
made for each sample. The final results obtained are shown in Table SI-2. MCM-41 calcined 
nanoparticles, showed a negative ζ value, due to the silanol groups present in the material’s 
surface. In relation to the prefunctionalized solid S1, a strong change in the sign of potential 
was induced, making it clearly positive because of the positive charges of the polyamine 
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moieties. And finally, as it was expected, S2 showed a low positive ζ value due to the presence 
of the ATP anions used as caps. 
 
Table SI-2. Physicochemical properties of the prepared solids. 
 EM (µm·cm/V·S) ζ (mV) σ (mS/cm) 
 MCM-41 calcined -2.719±0.004 -34.7±0.6 0.0171 
 S1      2.695±0.007 34.4±1.1 0.0544 
 S2 1.409±0.002 17.9±0.2 0.0207 
 
S3 characterization 
Scaffold series were characterized by standard techniques such as X-ray diffraction (XRD), 
thermogravimetry and SEM. In relation to the XRD pattern at low angle, a low angle 
diffraction peak was registered which can be attributed to the (100) reflexion typical of the 
hexagonal lattice p6m of the MCM-41 materials (see Figure SI-4). This fact indicated that the 
incorporation of the MSN nanoparticles in the scaffolds did not affect at the mesoporous 
structure of S2. Despite, when MSN were incorporated in the gelatin scaffold, a significant 
decrease in (100) reflexion peak was observed. This can be explained by a resolution loss in 
the maximum diffraction peaks of the mesoporous nanoparticles because of high gelatin 
content in the scaffold or because of a small degree of structural defects created in the 
lyophilization process.  
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Figure SI-4. XRD pattern of S2 nanoparticles and S3 scaffold.  
 
The performed thermogravimetric analysis (TGA) in the temperature range from 30ºC to 
950ºC determined the percentage contents of nanoparticles and gelatin incorporated in the ink 
for the scaffold printing. Several samples were analyzed by TG, in order to confirm the 
homogeneity of the method. From this technique, a 25% ± 3.2 weight content of SiO2 from S2 
nanoparticles was calculated. Then, from these data and S2 organic content quantification, it 
can be estimated that around a 35% in weight of the S3 scaffold is composed by S2 
nanoparticles  
Kinetic studies with S2 
In order to investigate the gat-ing properties of S2 material, two samples of 4 mg of S2 were 
suspended in 10 mL of water at 37 °C in the presence and in the absence of APase. The two 
samples were stirred at 200 rpm and then several 150µL aliquots were taken of each sample at 
different times. These aliquots were centrifuged at 9500 rpm and 110µL of the supernatant 
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was taken in order to monitor the [Ru(bpy)3]
2+ release (λex 454 nm, λem 593 nm) by 
fluorescence spectroscopy. 
S3 permeability assays 
An experimental assay with fluorescent avidin was carried out in order to demonstrate that the 
scaffold walls were permeable to macromolecules, and consequently APase could access to 
the MSN nanoparticles. For this assay a gelatin scaffold containing calcined MCM-41  
nanoparticles (the synthesis procedure was the same than the one described for S3 material, 
but containing non gated nanoparticles instead of S2) was immersed in a 4 mg/mL solution of 
fluorescent avidin in phosphate buffer solution (PBS) for 24 hours. Then, the scaffolds were 
intensely washed with fresh PBS in order to remove the externally adsorbed protein and cut in 
different levels in order to observe the fluorescence in the inner walls by fluorescence 
microscopy. The registered images showed fluorescence in all levels, which indicated that the 
scaffold walls were impregnated of avidin. 
Kinetic studies with S3 
In order to investigate the gating properties of S3 material, two S3 scaffolds were immersed in 
PBS solution (0.32 mL per gram of S3) at 37°C in the presence and in the absence of APase. 
The two samples were stirred at 200 rpm for 50 h and several 150µL aliquots were taken of 
each sample at different times. The fluorescence of the aliquots were registered (λex 454 nm, 
λem 593 nm) in order to monitor the [Ru(bpy)3]2+ release. 
 
Effect of the pH, the presence of other enzymes and denatured APase. 
Moreover, in order to determine the selectivity of the enzymatic action of phosphatase, 
several studies were carried out in presence of other enzymes, such as esterase (at pH 8) or 
pepsin (at pH 4), with S2 nanoparticles. Likewise, APase was denatured by heating at 70ºC 
for 1h, to prove that the dye delivery was produced due to the enzyme activity. It was used the 
same experimental procedure described above (see kinetic studies with S2). In Figure SI-5 it 
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can be observed that satisfactorily a strong dye delivery was produced in presence of APase at 
pH 4.8 (curve a) compared to the low release of dye in absence of enzyme in water at pH 4.8 
and at pH 8 (curves b and c) or with esterase, pepsin or denatured APase (curves d, e, f).  
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Figure SI-5. Kinetic of the dye release from S2 in the presence of APase at pH 4.8 (a) in the 
absence of enzyme at pH 4.8 (b) in the absence of enzyme at pH 8 (c) in the presence of 
esterase at pH 8 (d) in the presence of pepsin at pH 4 (e) in the presence of denatured APase. 
All in water at 37ºC. 
 
Biocompatibility studies  
In order to assess the biocompatibility, in vitro cell culture tests were carried out on 3D 
gelatin framework containing silica nanoparticles. A human osteoblast-like cell line denoted 
HOS was used. This cell line, obtained through the European Collection of Cell Cultures 
(ECACC, no. 87070202), was derived from an osteosarcoma of an old Caucasian female. The 
cells were cultured in Dulbecco’s modified Eagle medium (DMEM) containing 2 mM 
glutamine, 100 U/mL penicillin, 100 mg/mL streptomycin, and 10% fetal calf serum (FCS) at 
37°C in a humidified atmosphere of 95% air and 5% CO2. Osteoblast-like cells were routinely 
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subcultured by trypsinization. Before seeding, the scaffolds were conditioned by soaking in 
complete medium for 24 hours at 37ºC. 
 
Cell proliferation assay.  
 
For this particular assay, the cells were seeded onto the scaffolds surface in 24-well plates at a 
seeding density 4·104 cells·mL-1 in supplemented complete medium and incubated under 
standard conditions. Cell proliferation determinations were performed by using the MTT (3-
[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay at 3 and 5 days after 
seeding.  
 
Cytotoxicity assay: Lactate deshidrogenase (LDH) activity. 
 
LDH activity released from the osteoblast-like cells was considered for cell injury 
measurement. The measurements were made at 3 and 5 days of seeding by using a 
commercially available kit (Spinreact). 
 
Cell-spreading assay.  
 
The spreading degree and morphology of the osteoblast-like cells were visualized by SEM 
after 48 h. The attached cells were rinsed four times in PBS and fixed with 2.5% (v/v) 
glutaraldehyde in 0.1 M phosphate buffer. Dehydration was performed with slow water 
replacement by a series of graded ethanol solutions with final dehydration in absolute ethanol 
before critical-point drying. The materials were mounted on stubs, gold plated in vacuum 
using a sputter coater (Balzers SCD 004 (Wiesbaden-Nordenstadt, Germany), and analyzed 
by SEM in a JEOL 6400 microscope (Tokyo, Japan).  
 
Statistics 
 
Data obtained from biocompatibility are expressed as means ± standard deviations of the 
independent experiments indicated in each case. Statistical analysis was performed using the 
Statistical Package for the Social Sciences (SPSS) version 19 software. Statistical 
comparisons were made by analysis of variance (ANOVA). Scheffé test was used for post hoc 
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evaluation of difference among groups. In all statistical evaluations, p <0.05 was considered 
as statistically significant. 
 
The results obtained from the mitochondrial activity at 3 and 5 days (Figure SI-6) indicate 
that, in the presence of the scaffolds, HOS cells proliferate even better than in the control 
(plastic culture plate). For the same periods, the LDH levels do not show significant 
differences in the presence of the scaffolds compared with the control ones, indicating that the 
scaffolds do not elicit any cytotoxic effect (Figure SI-7).  
 
 
 
 
 
 
 
 
 
 
 
Figure SI-6. Cell proliferation assay after 3 and 5 days of culture. Significant differences 
were observed between the control and scaffolds results for cell proliferation tests. *(p<0.05). 
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Figure SI-7. LDH activity after 3 and 5 days of culture. 
 
HOS cells adhere, proliferate and spread well within the scaffold, as it is evidenced in SEM 
micrographs (Figure SI-8). The macroporous architecture and the strut thickness seem to be 
appropriated for the scaffold colonization by HOS cells. In fact, after 48 hours, the osteoblasts 
exhibit spread morphologies with numerous anchoring elements in both the most external and 
accessible surface, as well as within the macroporous channels tailored by means of the rapid 
prototyping method used in this work.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure SI-8. SEM micrographs of the scaffolds after 48 hours of HOS culture. (A) Detail of 
c.a. 900 mm macropore prepared by 3D printing.  The selected area indicates a fully coated 
border site by HOS cells; higher magnification of this area (B). (C) Transversal section of the 
scaffolds; double arrow points the channel width and dotted lines mark the struts. The selected 
area is magnified in (D), where spread HOS cells can be observed (arrows). 
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